Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression.
Nan XuJianyong ZhuoYiyuan ChenRenyi SuHuan ChenZhensheng ZhangZhengxing LianDi LuXuyong WeiShusen ZhengXiao XuShuai WangQiang WeiPublished in: British journal of cancer (2023)
Ac4C modification of myeloid cells enhanced the HCC immunotherapy by suppressing PDL1 expression.